MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PRONOSIS AND TREATMENT OF PROSTATE RELATED DISORDERS
Spain
14170625.9
Filed on 2009-02-27
14170625.9
Filed on 2009-02-27
MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PRONOSIS AND TREATMENT OF PROSTATE RELATED DISORDERS
Germany
14170625.9
Filed on 2009-02-27
14170625.9
Filed on 2009-02-27
MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PRONOSIS AND TREATMENT OF PROSTATE RELATED DISORDERS
Switzerland
14170625.9
Filed on 2009-02-27
14170625.9
Filed on 2009-02-27
MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PRONOSIS AND TREATMENT OF PROSTATE RELATED DISORDERS
China
201410133658.X
Filed on 2009-02-27
201410133658.X
Filed on 2009-02-27
MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PRONOSIS AND TREATMENT OF PROSTATE RELATED DISORDERS
Japan
2014-131080
Filed on 2014-06-26
2014-131080
Filed on 2014-06-26
MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PRONOSIS AND TREATMENT OF PROSTATE RELATED DISORDERS
Australia
2014202735
Filed on 2014-05-20
2014202735
Filed on 2014-05-20
Human Prostate Cancer MicroRNA Signature
US Application 15/480,753
Filed on 2017-04-06
Filed on 2017-04-06
MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PRONOSIS AND TREATMENT OF PROSTATE RELATED DISORDERS
Japan
2016-139495
Filed on 2016-07-14
2016-139495
Filed on 2016-07-14
MicroRNA Expression Signature for Predicting Survival and Metastases in Hepatocellular Carcinoma (miR-207, miR-219, miR-30c,miR-124a)
United Kingdom
07867402.5
Filed on 2007-11-01
07867402.5
Filed on 2007-11-01